Drugs / Guanxinshutong
Guanxinshutong
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02280850 | Oct 2014 → Jun 2015 | intermediate coronary syndrome | Shaanxi Buchang Pharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Guanxinshutong | “oral Guanxinshutong (GXST) capsules in Chinese patients with stable angina pectoris” PMID 31829173 ↗ Dec 2019 |
| Known as | Guanxin Shutong Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02280850 ↗ |
| Known as | GXST | “oral Guanxinshutong (GXST) capsules in Chinese patients with stable angina pectoris” PMID 31829173 ↗ Dec 2019 |